Telix Prescription drugs Restricted (TLX) Presents at H.C. Wainwright twenty seventh Annual International


Telix Prescription drugs Restricted (NASDAQ:TLX) H.C. Wainwright twenty seventh Annual International Funding Convention September 9, 2025 12:00 PM EDT

Firm Individuals

Christian Behrenbruch – Co-Founder, MD, Group CEO & Government Director

Convention Name Individuals

Robert Burns – H.C. Wainwright & Co, LLC, Analysis Division

Presentation

Robert Burns
Managing Director & Senior Healthcare Analyst

Welcome to our subsequent fireplace chat. I am Robert Burns, Managing Director and Senior Biotech Analyst, H.C. Wainwright. And I’m joined as we speak by Christian Behrenbruch, the CEO of Telix Prescription drugs. Christian, thanks for becoming a member of us as we speak.

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Sure. Thanks for the chance.

Query-and-Reply Session

Robert Burns
H.C. Wainwright & Co, LLC, Analysis Division

So one of many issues that I first needed to start out off with was clearly, Telix has skilled fast development and transformation through the years. So are you able to share a few of the key components which have contributed to the success?

Christian Behrenbruch
Co-Founder, MD, Group CEO & Government Director

Effectively, I feel the corporate is simply actually keen about radiopharmaceuticals. I feel one of many distinctive facets in regards to the firm is we do not actually consider in isotope platforms, proper? We expect that whenever you develop a radiopharmaceutical, you need to have a look at the scientific utility that you simply need to clear up.

It is best to take into consideration what pharmacophore achieves your organic goals finest. After which you need to select the appropriate isotope for the job. And so one of many issues that I feel is admittedly particular in regards to the firm, and it is mirrored within the infrastructure that we have constructed over the past — virtually — firm is sort of 10 years outdated, 8 years as a public firm is that agnosticism.

We would like a — we’re very — we’re a pure-play radio pharma firm. We consider that precision drugs is admittedly essential. That is form of one thing that is not



Source link

Related articles

thyssenkrupp AG (TKAMY) Q2 2026 Earnings Name Transcript

Comply withPlay Earnings NamePlay Earnings Name thyssenkrupp AG (TKAMY) Q2 2026 Earnings Name Could 12, 2026 5:00 AM EDT Firm Contributors Andreas Trösch - Head of Investor RelationsMiguel Angel Lopez Borrego...

Bitcoin Slips Under $80K After US Inflation Hits 3.8% and Price Reduce Hopes Fade

Key TakeawaysBitcoin fell under $80,000 on Might 12 as Trump warned that the U.S.-Iran ceasefire is on life assist.A 1.6% drop in crypto costs worn out $232 million in lengthy bets as bitcoin’s...

Revolut Steps Up Israel Hiring as It Pushes for “Lean Financial institution” License

Revolut is increasing its presence in Israel with a brand new hiring push, because the fintech large continues efforts to safe a lean financial institution license in the nation. The transfer follows its earlier approval...

Greatest AI Picture Mills of 2026

Accuracy is a vital issue to think about when evaluating AI picture turbines. Accuracy on this case refers to how nicely a service matches your immediate and the way clearly components and particulars...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com